|
Mar 29
|
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says
|
|
Mar 28
|
2 Top Biotech Buyout Candidates
|
|
Mar 28
|
Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
|
|
Mar 28
|
Insiders Are Dumping These 10 Healthcare Stocks
|
|
Mar 27
|
Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
|
|
Mar 26
|
Viking Therapeutics stock rises on positive Phase 1 weight-loss pill data
|
|
Mar 26
|
Viking Therapeutics Posts Promising Early Weight-Loss Data as Cost Worries Escalate
|
|
Mar 26
|
Novo Nordisk (NVO) to Buy Cardior to Boost Heart Disease Pipeline
|
|
Mar 26
|
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy?
|
|
Mar 26
|
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
|
|
Mar 26
|
32 Countries with the Highest Rates of Diabetes
|
|
Mar 25
|
Why the Market Dipped But Novo Nordisk (NVO) Gained Today
|
|
Feb 28
|
Weight loss drugs: Why state health providers should cover them
|
|
Feb 28
|
M&A on the horizon? Viking Therapeutics extends rally
|
|
Feb 28
|
EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows
|
|
Feb 28
|
Here's Why Novo Nordisk (NVO) is a Strong Momentum Stock
|
|
Feb 28
|
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
|
|
Feb 28
|
This Warren Buffett Stock Is On The Cusp Of Joining The $1 Trillion Club
|
|
Feb 27
|
Why Novo Nordisk and Eli Lilly Stocks Slipped Today
|
|
Feb 27
|
Stock Splits: Should You Buy?
|